BCM
ACGN

BlueCrest Capital Management’s Aceragen Inc ACGN Stock Holding History

BlueCrest Capital Management’s Portfolio ACGN Stock Details ACGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-2,771
Closed -$497K – 1875
2018
Q2 		$497K Buy
2,771
+2,679
+2,912% +$625K 0.01% 844
2018
Q1 		$23K Buy
92
+18
+24% +$4.94K ﹤0.01% 1448
2017
Q4 		$21K Buy
+74
New +$21.1K ﹤0.01% 795

Other funds holding ACGN

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlueCrest Capital Management's ACGN Position: Q3 2018 in Review

BlueCrest Capital Management sold out of Aceragen Inc (ACGN) in Q3 2018, closing a stake of 2,771 shares — an estimated $497K sold.

BlueCrest Capital Management first reported a position in ACGN in Q4 2017 and held it in 3 quarters. The position peaked at $497K in Q2 2018. 72 funds tracked by Wall St. Rank hold ACGN as of Q3 2018.

  • BlueCrest Capital Management reported no remaining Aceragen Inc position as of Q3 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 2,771 Aceragen Inc shares in Q3 2018, an estimated $497K.
  • BlueCrest Capital Management first reported a position in Aceragen Inc in Q4 2017 and held it in 3 quarters.
  • BlueCrest Capital Management's Aceragen Inc position peaked at $497K in Q2 2018.
  • 72 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2018.

Based on BlueCrest Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.